Pharmala Biotech Holdings Inc

11:19 AM EST - Pharmala Biotech Holdings Inc : Announces it has signed on to act as exclusive supplier of both GMP LaNeo™ MDMA and Engineering MDMA to InterVivo Solutions, its client companies and Affiliates. InterVivo Solutions is a well-established pre-clinical contract research organization with expertise in neuropsychiatric and neurological diseases. Together with Transpharmation, they form the largest boutique neuroscience-specialized in vivo CRO. Pharmala Biotech Holdings Inc shares C.MDMA are trading unchanged at $0.04.

Stocks in Play